Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Method Development and Validation of Valsartan and Its Impurities by High Performance Liquid Chromatography


Affiliations
1 Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam, Andhra Pradesh, 530045, India
     

   Subscribe/Renew Journal


Our main objective is to develop an accurate and precise HPLC method for the determination of valsartan and its impurities. An inertsil ODS-3v; (150 × 4.6) mm; 5 μm column is used for the Separation of drugs. The flow rate was maintained at 1.0 mL/min and the wave length used for detection was 230 nm. The linearity was observed in the range of 0.025-50μg/ml of spiked impurities in valsartan, impurity B and impurity C with a correlation coefficient of 0.990, 0.996 and 0.997 respectively. Linearity, accuracy, precision and robustness parameters for the suggested method were estimated for validation. The developed method can be utilized in the analysis of valsartan tablets.

Keywords

HPLC, Method Validation, Related Impurities, Entacapone, LOQ, LOD.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 251

PDF Views: 5




  • Method Development and Validation of Valsartan and Its Impurities by High Performance Liquid Chromatography

Abstract Views: 251  |  PDF Views: 5

Authors

O. S. S. Chandana
Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam, Andhra Pradesh, 530045, India
R. Ravichandra Babu
Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam, Andhra Pradesh, 530045, India

Abstract


Our main objective is to develop an accurate and precise HPLC method for the determination of valsartan and its impurities. An inertsil ODS-3v; (150 × 4.6) mm; 5 μm column is used for the Separation of drugs. The flow rate was maintained at 1.0 mL/min and the wave length used for detection was 230 nm. The linearity was observed in the range of 0.025-50μg/ml of spiked impurities in valsartan, impurity B and impurity C with a correlation coefficient of 0.990, 0.996 and 0.997 respectively. Linearity, accuracy, precision and robustness parameters for the suggested method were estimated for validation. The developed method can be utilized in the analysis of valsartan tablets.

Keywords


HPLC, Method Validation, Related Impurities, Entacapone, LOQ, LOD.